Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy

The aims of the study were to determine whether symmetric dimethylarginine (SDMA) was increased in dogs with leishmaniosis and to assess its relationship with creatinine concentration and urinary protein : creatinine ratio (UPC) to determine its utility as a marker of early excretory dysfunction. Fi...

Full description

Saved in:
Bibliographic Details
Main Authors: Esther Torrent, Marta Planellas, Laura Ordeix, Josep Pastor, Jaume Rodon, Laia Solano-Gallego
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Veterinary Medicine International
Online Access:http://dx.doi.org/10.1155/2018/7517359
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550107506016256
author Esther Torrent
Marta Planellas
Laura Ordeix
Josep Pastor
Jaume Rodon
Laia Solano-Gallego
author_facet Esther Torrent
Marta Planellas
Laura Ordeix
Josep Pastor
Jaume Rodon
Laia Solano-Gallego
author_sort Esther Torrent
collection DOAJ
description The aims of the study were to determine whether symmetric dimethylarginine (SDMA) was increased in dogs with leishmaniosis and to assess its relationship with creatinine concentration and urinary protein : creatinine ratio (UPC) to determine its utility as a marker of early excretory dysfunction. Fifty-three dogs with leishmaniosis classified according to the LeishVet clinical staging (stage I, n=5, stage II, n=30; stage III, n=12; stage IV, n=6) were selected and compared with 41 clinically healthy dogs. Thirty-nine dogs with leishmaniosis were also followed up for six months. SDMA concentrations on the day of diagnosis were significantly higher in dogs with leishmaniosis with respect to control dogs and in dogs from LeishVet stage IV when compared with the other stages. Increased UPC (>0.5), SDMA (>19 μg/dL), and creatinine concentrations (≥1.4 mg/dL) were found in 47.1%, 15.1%, and 9.4% of dogs with leishmaniosis, respectively. SDMA concentration was increased in 24% of proteinuric dogs, in 7% of nonproteinuric dogs, and in four of five dogs with increased creatinine. SDMA concentration ≥ 25 μg/dL was associated with clinical chronic kidney disease (CKD) after six months. Our results did not demonstrate advantages in using SDMA concentration as an early marker of CKD when compared to creatinine and UPC in canine leishmaniosis.
format Article
id doaj-art-f41767e0bcd24cbfba82431144b37b45
institution Kabale University
issn 2090-8113
2042-0048
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Veterinary Medicine International
spelling doaj-art-f41767e0bcd24cbfba82431144b37b452025-02-03T06:07:50ZengWileyVeterinary Medicine International2090-81132042-00482018-01-01201810.1155/2018/75173597517359Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced NephropathyEsther Torrent0Marta Planellas1Laura Ordeix2Josep Pastor3Jaume Rodon4Laia Solano-Gallego5Fundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, Barcelona, SpainFundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, Barcelona, SpainFundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, Barcelona, SpainDepartament de Medicina i Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Barcelona, SpainIDEXX Laboratorios, Barcelona, SpainDepartament de Medicina i Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Barcelona, SpainThe aims of the study were to determine whether symmetric dimethylarginine (SDMA) was increased in dogs with leishmaniosis and to assess its relationship with creatinine concentration and urinary protein : creatinine ratio (UPC) to determine its utility as a marker of early excretory dysfunction. Fifty-three dogs with leishmaniosis classified according to the LeishVet clinical staging (stage I, n=5, stage II, n=30; stage III, n=12; stage IV, n=6) were selected and compared with 41 clinically healthy dogs. Thirty-nine dogs with leishmaniosis were also followed up for six months. SDMA concentrations on the day of diagnosis were significantly higher in dogs with leishmaniosis with respect to control dogs and in dogs from LeishVet stage IV when compared with the other stages. Increased UPC (>0.5), SDMA (>19 μg/dL), and creatinine concentrations (≥1.4 mg/dL) were found in 47.1%, 15.1%, and 9.4% of dogs with leishmaniosis, respectively. SDMA concentration was increased in 24% of proteinuric dogs, in 7% of nonproteinuric dogs, and in four of five dogs with increased creatinine. SDMA concentration ≥ 25 μg/dL was associated with clinical chronic kidney disease (CKD) after six months. Our results did not demonstrate advantages in using SDMA concentration as an early marker of CKD when compared to creatinine and UPC in canine leishmaniosis.http://dx.doi.org/10.1155/2018/7517359
spellingShingle Esther Torrent
Marta Planellas
Laura Ordeix
Josep Pastor
Jaume Rodon
Laia Solano-Gallego
Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy
Veterinary Medicine International
title Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy
title_full Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy
title_fullStr Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy
title_full_unstemmed Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy
title_short Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy
title_sort serum symmetric dimethylarginine as an early marker of excretory dysfunction in canine leishmaniosis l infantum induced nephropathy
url http://dx.doi.org/10.1155/2018/7517359
work_keys_str_mv AT esthertorrent serumsymmetricdimethylarginineasanearlymarkerofexcretorydysfunctionincanineleishmaniosislinfantuminducednephropathy
AT martaplanellas serumsymmetricdimethylarginineasanearlymarkerofexcretorydysfunctionincanineleishmaniosislinfantuminducednephropathy
AT lauraordeix serumsymmetricdimethylarginineasanearlymarkerofexcretorydysfunctionincanineleishmaniosislinfantuminducednephropathy
AT joseppastor serumsymmetricdimethylarginineasanearlymarkerofexcretorydysfunctionincanineleishmaniosislinfantuminducednephropathy
AT jaumerodon serumsymmetricdimethylarginineasanearlymarkerofexcretorydysfunctionincanineleishmaniosislinfantuminducednephropathy
AT laiasolanogallego serumsymmetricdimethylarginineasanearlymarkerofexcretorydysfunctionincanineleishmaniosislinfantuminducednephropathy